CORE LABS INC (CLB)
(Delayed Data from NYSE)
$18.58 USD
-0.01 (-0.05%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $18.58 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.58 USD
-0.01 (-0.05%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $18.58 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Zacks News
Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BKR or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BKR vs. CLB: Which Stock Is the Better Value Option?
Core Laboratories (CLB) Up 6.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates
by Zacks Equity Research
Core Laboratories' (CLB) second-quarter 2024 revenues are anticipated to be in the $130-$136 million range, while the operating income is estimated to be in the band of $14.5-$17.3 million.
Kinder Morgan (KMI) Beats on Q1 Earnings, Hikes Dividend
by Zacks Equity Research
Kinder Morgan's (KMI) Q1 earnings gain from increased financial contributions from the Natural Gas Pipelines, Products Pipelines and Terminals business segments.
Sunoco (SUN) Proceeds With Strategic Portfolio Optimization
by Zacks Equity Research
Despite the significant structural changes, Sunoco (SUN) maintains its financial outlook for 2024. The company projects 2024 adjusted EBITDA between $975 million and $1 billion.
What Makes Core Laboratories (CLB) a New Strong Buy Stock
by Zacks Equity Research
Core Laboratories (CLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Core Laboratories (CLB) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Core Laboratories (CLB) Down 0.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q4 Earnings Miss Estimates, Sales In Line
by Zacks Equity Research
Core Laboratories' (CLB) first-quarter 2024 revenues are anticipated in the $122-$128 million range, while the operating income is estimated in the band of $11.8-$14.3 million.
Here's What Key Metrics Tell Us About Core Laboratories (CLB) Q4 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Core Laboratories (CLB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Core Laboratories (CLB) Q4 Earnings Miss Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of -5% and 0.32%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Liberty Oilfield Services (LBRT) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Liberty Oilfield Services (LBRT) delivered earnings and revenue surprises of -5.26% and 0.58%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories (CLB) Reports Next Week: What You Should Expect
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Halliburton (HAL) Tops Q4 Earnings Estimates
by Zacks Equity Research
Halliburton (HAL) delivered earnings and revenue surprises of 7.50% and 0.80%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Phillips 66 (PSX) Announces $2.2B Capital Expenditure for 2024
by Zacks Equity Research
The budget aligns with Phillips 66's (PSX) strategic goal of returning $13-$15 billion to shareholders by the end of 2024.
Petrobras (PBR) Signs Rig Extension Deals With Constellation
by Zacks Equity Research
Petrobras (PBR) signs rig extension contracts with Constellation Oil Services, securing continued operations for two important rigs in its offshore drilling fleet.
Shell (SHEL) Plans Two-Well Drilling Campaign in the North Sea
by Zacks Equity Research
Shell's (SHEL) 2024 North Sea drilling targets Selene and Pensacola, showcasing its commitment to European energy security and innovation.
Down -7.87% in 4 Weeks, Here's Why Core Laboratories (CLB) Looks Ripe for a Turnaround
by Zacks Equity Research
Core Laboratories (CLB) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
3 Energy Stocks Priced Under $100 to Bet on Right Away
by Nilanjan Banerjee
It's an opportune moment for investors to incorporate energy stocks like The Williams Companies, Inc. (WMB), Matador Resources Company (MTDR) and Core Laboratories Inc. (CLB) in their portfolio.
Core Laboratories (CLB) Down 16.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q3 Earnings Top, Revenues Miss
by Zacks Equity Research
Core Laboratories (CLB) anticipates revenues in the range of $125-$132 million and operating income in the band of $13.8-$17.3 million for the fourth quarter of 2023. It also expects earnings per share in the 17-23 cents range.
Core Laboratories (CLB) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Core Laboratories (CLB) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.